Tagraxofusp

Tagraxofusp is a prescription medication used to treat certain types of blood cancers. It is a targeted, cancer-fighting drug (also known as a targeted therapy) that works by blocking a cancer cell protein called CD123. Tagraxofusp is used to treat a type of blood cancer called blastic plasmacytoid dendritic cell neoplasm (BPDCN). Tagraxofusp is typically given as an intravenous (IV) infusion once every two weeks.

Tagraxofusp is a medication specifically designed to treat a rare blood cancer known as blastic plasmacytoid dendritic cell neoplasm (BPDCN). Here's a closer look at its key features:

What it treats:

• Tagraxofusp targets BPDCN, a cancer affecting the immune system. It develops from a type of white blood cell called a plasmacytoid dendritic cell.

How it works:

• Tagraxofusp is a fusion protein engineered by combining two components:
  • Interleukin-3 (IL-3): This molecule normally helps certain immune cells grow and mature.
  • Diphtheria toxin: This toxin is modified to target and kill cells expressing a specific protein (CD123) found on the surface of BPDCN cells.
• By binding to CD123, Tagraxofusp delivers the diphtheria toxin specifically to BPDCN cells, disrupting their protein synthesis and causing cell death.

Brand Name and Availability:

• Tagraxofusp is sold under the brand name Elzonris.

Dosage and Administration:

• Tagraxofusp is given as an intravenous (IV) infusion into a vein by a healthcare professional.
• The specific dosing schedule depends on your individual needs and is determined by your doctor.

Benefits:

• Tagraxofusp offers a targeted treatment option for BPDCN, a previously challenging-to-treat cancer.
• It can potentially induce remission (reduction or disappearance of cancer) and improve symptoms.

Side Effects:

• Tagraxofusp can cause some serious side effects, including:
  • Severe capillary leak syndrome (leaking of fluid from blood vessels)
  • Hypersensitivity reactions (allergic reactions)
  • Low blood cell counts
  • Fatigue
  • Nausea
  • Vomiting